LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
MDA-MB-231 | SB590885 | 0.04 | uM | LJP5 | 1.0040 | 0.0083 | 1.0057 | 0.0113 |
MDA-MB-231 | PIK-93 | 0.04 | uM | LJP5 | 1.0190 | 0.0173 | 1.0254 | 0.0235 |
MDA-MB-231 | KIN001-043 | 0.04 | uM | LJP6 | 0.9212 | 0.0420 | 0.8922 | 0.0582 |
MDA-MB-231 | Alpelisib | 0.04 | uM | LJP5 | 1.0071 | 0.0184 | 1.0093 | 0.0250 |
MDA-MB-231 | Luminespib | 0.04 | uM | LJP5 | 0.2292 | 0.0346 | -0.0448 | 0.0560 |
MDA-MB-231 | A443654 | 0.04 | uM | LJP6 | 0.6438 | 0.1366 | 0.5208 | 0.1794 |
MDA-MB-231 | OSI-027 | 0.04 | uM | LJP6 | 1.0262 | 0.0159 | 1.0351 | 0.0212 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 0.7804 | 0.0204 | 0.7031 | 0.0254 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 0.9571 | 0.0607 | 0.9404 | 0.0821 |
MDA-MB-231 | WH-4-025 | 0.04 | uM | LJP5 | 0.8404 | 0.0192 | 0.7841 | 0.0250 |
MDA-MB-231 | WZ-4-145 | 0.04 | uM | LJP6 | 0.8022 | 0.0344 | 0.7323 | 0.0462 |
MDA-MB-231 | XMD16-144 | 0.04 | uM | LJP5 | 0.4504 | 0.0641 | 0.2544 | 0.0932 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 0.9194 | 0.0663 | 0.8915 | 0.0888 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 1.0584 | 0.0212 | 1.0785 | 0.0278 |
MDA-MB-231 | BX-912 | 0.04 | uM | LJP5 | 0.9174 | 0.0209 | 0.8887 | 0.0272 |
MDA-MB-231 | Canertinib | 0.04 | uM | LJP6 | 1.0353 | 0.0328 | 1.0470 | 0.0438 |
MDA-MB-231 | Celastrol | 0.04 | uM | LJP6 | 1.0720 | 0.0283 | 1.0980 | 0.0392 |
MDA-MB-231 | CGP60474 | 0.04 | uM | LJP5 | 0.7295 | 0.0233 | 0.6340 | 0.0295 |
MDA-MB-231 | CGP60474 | 0.04 | uM | LJP6 | 0.1843 | 0.0379 | -0.1057 | 0.0620 |
MDA-MB-231 | CHIR-99021 | 0.04 | uM | LJP6 | 0.8957 | 0.0180 | 0.8586 | 0.0249 |
MDA-MB-231 | CP724714 | 0.04 | uM | LJP5 | 0.9137 | 0.0854 | 0.8854 | 0.1145 |
MDA-MB-231 | CP466722 | 0.04 | uM | LJP5 | 1.0624 | 0.0164 | 1.0841 | 0.0213 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 0.8525 | 0.0824 | 0.8024 | 0.1097 |
MDA-MB-231 | Momelotinib | 0.04 | uM | LJP5 | 0.8775 | 0.0418 | 0.8349 | 0.0548 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 0.5140 | 0.0411 | 0.3428 | 0.0507 |